Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × pertuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Neoplasms 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 HER2-positive Breast Cancer 2 Triple Negative Breast Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Malignant Solid Neoplasm 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Early Breast Cancer 1 Endometrial Neoplasms 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Azacitidine 7 venetoclax 6 Specimen Handling 6 Biopsy 6 Injections 5 Stem Cell Transplantation 4 Decitabine 4 Cytarabine 4 fludarabine 3 Cyclophosphamide 3 olutasidenib 2 fludarabine phosphate 2 decitabine and cedazuridine drug combination 2 cedazuridine 2 X-Rays 2 Whole-Body Irradiation 2 Vorinostat 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclosporins 2 Cyclosporine 2 Cladribine 2 Carboplatin 2 CPX-351 2 veliparib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡